We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to prepare and what to do if you’re affected by extreme weather and natural hazards while travelling or living abroad.
The characteristics, diagnosis, management, surveillance and epidemiology of Staphylococcus aureus.
This document explains the NHS view on private screening for different conditions and diseases.
Guidance and information about high consequence infectious diseases and their management in England.
Guidance for health professionals on diagnoses, prevention and treatment of meningococcal disease.
Examples of viral haemorrhagic fevers (VHFs) include Lassa fever, Crimean-Congo haemorrhagic fever, Marburg and Ebola virus diseases.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Clinicians are provided with actions to complete when managing infectious diseases in the asylum seeker population.
Chief Medical Officer for England, Professor Chris Whitty's annual reports and lectures on medicine and public health.
The symptoms, diagnosis, management, surveillance and epidemiology of of typhoid and paratyphoid (enteric fever).
Guidance primarily aimed at local responders covering some humanitarian issues that may arise during the recovery phase of an emergency in the UK.
The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.